Free Trial

Nutrien Ltd. (NYSE:NTR) Short Interest Up 84.8% in September

Nutrien logo with Basic Materials background

Key Points

  • Nutrien Ltd. experienced an **84.8% increase** in short interest in September, with a total of **9,720,000 shares** sold short, indicating heightened bearish sentiment among investors.
  • The company's stock traded down **2.7%** to reach **$56.04**, while Nutrien reported earnings of **$2.65 per share** for the last quarter, surpassing expectations.
  • Nutrien declared a quarterly dividend of **$0.545**, providing a **3.9% yield**, with institutional investors owning **63.10%** of the company's stock.
  • MarketBeat previews the top five stocks to own by November 1st.

Nutrien Ltd. (NYSE:NTR - Get Free Report) saw a significant growth in short interest in September. As of September 30th, there was short interest totaling 9,720,000 shares, a growth of 84.8% from the September 15th total of 5,260,000 shares. Based on an average daily trading volume, of 2,460,000 shares, the days-to-cover ratio is currently 4.0 days. Approximately 2.0% of the shares of the company are sold short. Approximately 2.0% of the shares of the company are sold short. Based on an average daily trading volume, of 2,460,000 shares, the days-to-cover ratio is currently 4.0 days.

Nutrien Trading Down 2.7%

Shares of NYSE:NTR traded down $1.53 during midday trading on Tuesday, hitting $56.04. 2,944,573 shares of the stock were exchanged, compared to its average volume of 3,138,759. The stock has a market capitalization of $27.19 billion, a price-to-earnings ratio of 20.09, a P/E/G ratio of 0.95 and a beta of 0.82. The company has a debt-to-equity ratio of 0.39, a quick ratio of 0.85 and a current ratio of 1.33. The business's 50-day moving average price is $57.80 and its 200 day moving average price is $57.68. Nutrien has a 12 month low of $43.69 and a 12 month high of $65.08.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $2.65 earnings per share for the quarter, topping the consensus estimate of $2.41 by $0.24. The company had revenue of $10.30 billion for the quarter, compared to analysts' expectations of $10.40 billion. Nutrien had a return on equity of 6.51% and a net margin of 5.25%.The business's quarterly revenue was up 2.8% compared to the same quarter last year. During the same period in the previous year, the business posted $2.34 earnings per share. Analysts predict that Nutrien will post 3.72 earnings per share for the current year.

Nutrien Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 17th. Shareholders of record on Monday, September 29th were paid a $0.545 dividend. The ex-dividend date of this dividend was Monday, September 29th. This represents a $2.18 annualized dividend and a yield of 3.9%. Nutrien's payout ratio is 78.14%.

Wall Street Analysts Forecast Growth

NTR has been the subject of a number of analyst reports. TD Securities boosted their price target on Nutrien from $70.00 to $72.00 and gave the company a "buy" rating in a research note on Monday, August 11th. Bank of America reaffirmed a "neutral" rating and issued a $67.00 price target on shares of Nutrien in a research note on Tuesday, October 14th. Jefferies Financial Group dropped their price target on Nutrien from $61.00 to $60.00 and set a "hold" rating for the company in a research note on Tuesday, September 9th. Barclays lifted their target price on Nutrien from $61.00 to $64.00 and gave the company an "equal weight" rating in a research report on Monday, July 7th. Finally, Morgan Stanley lifted their target price on Nutrien from $60.00 to $65.00 and gave the company an "equal weight" rating in a research report on Thursday, June 26th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Nutrien presently has a consensus rating of "Hold" and a consensus target price of $62.78.

Read Our Latest Research Report on NTR

Hedge Funds Weigh In On Nutrien

Several institutional investors have recently added to or reduced their stakes in NTR. GAMMA Investing LLC lifted its stake in Nutrien by 4,866.7% in the first quarter. GAMMA Investing LLC now owns 1,043 shares of the company's stock valued at $52,000 after buying an additional 1,022 shares during the period. Wealth Enhancement Advisory Services LLC lifted its stake in Nutrien by 184.1% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 12,243 shares of the company's stock valued at $608,000 after buying an additional 7,934 shares during the period. Blue Trust Inc. lifted its stake in Nutrien by 78.2% in the first quarter. Blue Trust Inc. now owns 6,078 shares of the company's stock valued at $302,000 after buying an additional 2,668 shares during the period. Sava Infond d.o.o. raised its position in shares of Nutrien by 50.9% during the first quarter. Sava Infond d.o.o. now owns 35,550 shares of the company's stock worth $1,766,000 after purchasing an additional 11,990 shares during the period. Finally, Moran Wealth Management LLC raised its position in shares of Nutrien by 36.5% during the first quarter. Moran Wealth Management LLC now owns 18,729 shares of the company's stock worth $929,000 after purchasing an additional 5,008 shares during the period. 63.10% of the stock is owned by institutional investors and hedge funds.

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.